Monoclonal Antibody Treatment for COVID-19 Now Available
Friday, December 18, 2020
COVID-19 monoclonal antibody (MAb) therapy drugs authorized by the FDA for emergency use are now available as an intravenous therapy.
COVID-19 monoclonal antibody (MAb) therapy drugs authorized by the FDA for emergency use are now available as an intravenous therapy.